1. NICM HRI Home
  2. Research
  3. Research Projects
  4. Medicinal Cannabis and Endometriosis

Medicinal Cannabis and Endometriosis

NICM Health Research Institute's Associate Professor Mike Amour is leading a number of medicinal cannabis studies in endometriosis and other gynaecological and menstrual conditions.

The multidisciplinary projects will involve academics, researchers, medical professionals and endometriosis advocates from Western Sydney University, Deakin University, Macquarie University, University of Tasmania, UNSW Sydney, the University of Sydney, the Medical Research Institute of New Zealand, Royal Hospital for Women in Randwick, Endometriosis Australia and the National Endometriosis Clinical and Scientific Trials Network.

Currently planned are two separate randomised controlled trials looking at the effect of various types of medicinal cannabis on endometriosis. One trial will be conducted in Sydney, and the other in Victoria. Preclinical studies are also planned that will look at how medicinal cannabis can affect things like blood flow in various parts of the body including to the uterus.

Our first clinical trial has started in Victoria. We expect our Sydney study to start in Feb 2024.

Interested in participating?

Complete the form below to register your interest and receive up to date information about these upcoming endometriosis studies.

Please note this form is for general expressions of interest only. Registering your interest does not commit you to participate in a current or future clinical trial. You will receive correspondence from our clinical trials team about the upcoming studies and your eligibility once recruitment for each trial commences.

What menstrual or gynaecological condition(s) do you have?
Select all that apply.

Clinical trial Principal Investigator Associate Professor Mike Armour.